• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

Guttman, Buschner & Brooks

  • Home
  • Areas of Practice
    • High Impact Litigation
    • Whistleblower and False Claim Cases
    • Employment Litigation and Civil Rights – Employees
    • Employment Counseling and Litigation – Employers
    • Corporate Governance
  • Successes
  • Articles
  • Attorneys
    • Justin S. Brooks
    • Traci L. Buschner
    • Judge Nancy Gertner (Ret.)
    • Dan Guttman
    • Reuben A. Guttman
    • Dr. Caroline Poplin
    • Elizabeth H. Shofner
    • Aaron Welo
  • Amicus
  • Videos
  • Contact Us
    • Twitter
    • Facebook
    • LinkedIn

December 19, 2015 By Staff

Reuben Guttman: The lawyer pharma loves to hate

Reuben Guttman wants us all to be concerned about what’s in our medicine cabinets. A Washington lawyer who specializes in prosecuting pharmaceutical fraud, Guttman has gone after Pfizer, Abbott, GlaxoSmithKline, and several other top drug makers — and he usually wins big, recouping billions of dollars for federal and state governments.

We invite you to read the full interview with Mr. Guttman conducted by By Karen Weintraub of StatNews.com

Primary Sidebar

Information

  • Where to Start
  • Whistleblower Information
  • Federal & State False Claims Acts
  • Protecting Whistleblowers

Footer

Guttman, Buschner & Brooks PLLC

Washington DC Office NEW!
Embassy Row District
1509 22nd Street, NW
Washington, D.C. 20037
Phone: 202-800-3001



Pennsylvania Office: New!
450 N. Narberth Avenue
Suite 102
Narberth, PA 19072
(610) 547-9556
CLE: GBB partner, Reuben Guttman, and Professor JC Lore of Rutgers Law to present CLE covering topic in their book, Pretrial Advocacy, Wolters Kluwer-NITA (2021).” To register or learn More
More about the book here

Articles

The Travesty of The US News Rankings: How Legal Education Should Be Measured

Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements

Webinar: Non-state actors and global environmental governance in China

More Articles

Copyright © 2023 · Guttman, Buschner & Brooks PLLC
Disclaimer